More Help for Two Types of Lymphoma

(MedPage Today) -- WASHINGTON--The FDA granted accelerated approval to the PI3K inhibitor umbralisib (Ukoniq) for two types of relapsed/refractory lymphoma, said manufacturer TG Therapeutics.
The approval encompasses patients with marginal...